| Field | Before | After |
|---|---|---|
| Field Last Published | Before November 23, 2013 02:22 PM | After December 15, 2013 03:31 AM |
| Field Is there a restricted access data set available on request? | Before | After No |
| Field Program Files | Before | After No |
| Field Is data available for public use? | Before | After No |
| Field | Before | After |
|---|---|---|
| Field Paper Abstract | Before PRIVATE SECTOR PERSPECTIVE (DUNAVANT): ECONOMIC EFFECTS Building on nonexperimental literature on the economic impact of malaria, this paper evaluates the commercial impact of a private sector malaria control project in Zambia’s cotton industry. Using a cluster randomized trial involving 81,597 smallholder cotton farmers in 1,507 clusters, I evaluate whether the distribution of free insecticide-treated mosquito nets at the outset of malaria season increased farmer’s cotton production sufficiently to be commercially viable for the implementing agribusiness. But despite large health effects, I do not detect any impact on cotton deliveries to the business. I conclude that the independent and sustained distribution of free bed nets by Zambia’s cotton industry is unlikely to materialize without subsidies. More generally, the results question widespread narratives about the economic impact of malaria control, as well as the ability of standard economic models to explain the labor decisions of smallholder farmers. | After PRIVATE SECTOR PERSPECTIVE (DUNAVANT): ECONOMIC EFFECTS see URL |
| Field Paper URL | Before http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2358045 | After http://ssrn.com/abstract=2358045 |
| Field | Before | After |
|---|---|---|
| Field Paper Abstract | Before PUBLIC SECTOR PERSPECTIVE (NMCP): HEALTH EFFECTS The distribution effectively reached target beneficiaries, with approximately 95% of households in the treatment group reporting that they had received an ITN through the programme. The average increase in the fraction of household members sleeping under an ITN the night prior to the interview was 14.6 percentage points (p-value <0.001). Treatment was associated with a 42 percent reduction in the odds of self-reported fever (p-value <0.001) and with a 49 percent reduction in the odds of self-reported malaria (p-value 0.002). This was accomplished at a cost of approximately five US$ per ITN to Zambia’s NMCP. | After PUBLIC SECTOR PERSPECTIVE (NMCP): HEALTH EFFECTS see URL |